Dr Mark McMillan
Grant-Funded Research Fellow
School of Medicine
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Mark McMillan moved from a clinical background as a Registered Nurse, working across a broad range of disciplines, including Aboriginal primary health care, infection control, renal dialysis, rehabilitation, public health, high dependency, and tropical infectious diseases. In 2008, he began his research career at the Menzies School of Health Research in Darwin. In 2013, he joined the Vaccine Trials Research Unit at the Women's and Children's Hospital, Adelaide.Dr. McMillan completed his PhD in May 2021, receiving a Dean’s Commendation and The Alice Davey Award for his work on meningococcal carriage and disease, which contributed to national immunisation strategies for meningococcal B disease.Since 2020, Dr. McMillan has led the Vaccine Program Evaluation team at the Women's and Children's Hospital, conducting commissioned reviews for SA Health, including evaluations of South Australia's COVID-19 vaccine program and school immunisation program. He has also led three commissioned evaluations and drafting of advice for the Australian Technical Advisory Group on Immunisation (ATAGI).Dr. McMillan is a Chief Investigator (CIJ) on the Centre for Research Excellence in Neisseria Disease Control (NEIS CRE), which focuses on developing public health strategies to reduce the burden of invasive meningococcal disease (IMD) and gonorrhoea. In 2023, he was awarded the Women’s & Children’s Hospital Foundation Postdoctoral Fellowship to investigate the long-term effects of COVID-19 and influenza infection on the health and wellbeing of children and adolescents.
| Date | Position | Institution name |
|---|---|---|
| 2023 - ongoing | Research Fellow - Lead of Vaccine Program Evaluation | University of Adelaide |
| 2014 - 2023 | Research Associate | University of Adelaide |
| 2013 - 2014 | Research Fellow | University of Adelaide |
| 2010 - 2013 | Continuous Quality Improvement Coordinator | Watto Purrunna Aboriginal Primary Health Care |
| 2009 - 2010 | Senior Policy Officer and Co-ordinator | Centre for Disease Control |
| 2007 - 2009 | Research Officer Menzies School of Health | Menzies School of Health Research |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2017 - 2021 | Doctor of Philosophy | University of Adelaide | Australia |
| 2015 - 2016 | Graduate Certificate in Epidemiology | University of Queensland | Australia |
| 2012 - 2014 | Master of Clinical Science | University of Adelaide | Australia |
| 2008 - 2010 | Graduate Diploma Health Promotion | Deakin University | Australia |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 1989 | Registered Nurse | Queen Elizabeth Hospital | Australia |
| Year | Citation |
|---|---|
| 2025 | Pham-Tran, D. D., Leong, L. E. X., McMillan, M., Lawrence, A., Mohammed, H., Finn, A., & Marshall, H. S. (2025). The lack of specificity of <i>sodC</i> -based PCR for the detection of <i>Neisseria meningitidis</i> carriage in pharyngeal swabs from adolescents. Microbiology Spectrum, 13(5), 8 pages. Scopus2 WoS1 Europe PMC1 |
| 2025 | Wang, B., Giles, L., Andraweera, P., McMillan, M., Beazley, R., Almond GradCert, S., . . . Marshall, H. (2025). Long-term protection against invasive meningococcal B disease and gonococcal infection five years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study.. Clin Infect Dis, 81(4), e202-e210. Scopus4 WoS2 Europe PMC2 |
| 2025 | Coldbeck-Shackley, R. C., Lawrence, A., McMillan, M., Selway, C. A., Papanicolas, L., Turra, M., . . . Leong, L. E. X. (2025). Direct whole-genome sequencing enables strain typing of unculturable Neisseria meningitidis from oropharyngeal carriage specimens. Microbial genomics, 11(8), 001464-1-001464-14. |
| 2025 | McMillan, M., Buttery, J., Angliss, M., Barton, B., Synn, A., Blyth, C. C., . . . Marshall, H. S. (2025). Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults.. Pediatr Infect Dis J, 45(1), 17-23. |
| 2025 | Clarke, M., McMillan, M., Giles, L. C., Riley, K., Andraweera, P., Richmond, P. C., . . . Marshall, H. S. (2025). The impact of obesity on influenza Vaccine immunogenicity: A systematic review. Vaccine, 65, 127794. |
| 2024 | Leong, L. E. X., Coldbeck-Shackley, R. C., McMillan, M., Bratcher, H. B., Turra, M., Lawrence, A., . . . Marshall, H. (2024). The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent population. The Lancet Regional Health. Western Pacific, 43(100966), 10 pages. Scopus5 WoS5 Europe PMC2 |
| 2024 | Milazzo, A., McMillan, M., Giles, L., Page, K., Flood, L., & Marshall, H. (2024). The geographic distribution of invasive meningococcal disease and carriage: A spatial analysis. Epidemiology and Infection, 152, e22-1-e22-11. |
| 2024 | McMillan, M., Mohammed, H., Bednarz, J., Leong, L. E. X., Lawrence, A., Sullivan, T. R., . . . Marshall, H. S. (2024). Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020.. The Journal of infection, 88(2), S0163-4453(24)00021-5. Scopus3 WoS2 Europe PMC2 |
| 2024 | Mohammed, H., Peut, C., McMillan, M., Wang, B., Sullivan, T. R., & Marshall, H. S. (2024). THE ROLE OF SCHOOLS IN MENINGOCOCCAL CARRIAGE AMONG ADOLESCENTS AND YOUNG ADULTS IN SOUTH AUSTRALIA.. Pediatr Infect Dis J, 43(7), e249-e251. |
| 2024 | Marshall, H., Ward, J., Wang, B., Andraweera, P., McMillan, M., Flood, L., . . . Lahra, M. M. (2024). Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol. BMJ Open, 14(5), e079144-1-e079144-8. Scopus2 WoS2 Europe PMC1 |
| 2024 | McMillan, M., McDonough, J., Angliss, M., Buttery, J., Saunders, L., Mathew, S. M., . . . Marshall, H. S. (2024). Exploring the health-related quality of life and the lived experience of adolescents following invasive meningococcal disease. Healthcare, 12(11, article no. 1075), 1-15. Scopus3 WoS3 Europe PMC3 |
| 2024 | Wang, B., Mohammed, H., Andraweera, P., McMillan, M., & Marshall, H. (2024). Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. Journal of Infection, 89(3), 10 pages. Scopus16 WoS14 Europe PMC10 |
| 2024 | Wang, B., Giles, L., Andraweera, P., McMillan, M., Beazley, R., Sisnowski, J., . . . Marshall, H. (2024). Long-term 4CMenB vaccine effectiveness against gonococcal infection at four years post program implementation: observational case-control study. Open Forum Infectious Diseases, 12(1), ofae726-1-ofae726-7. Scopus6 WoS3 Europe PMC6 |
| 2023 | Mohammed, H., Pham-Tran, D. D., Yeoh, Z. Y. M., Wang, B., McMillan, M., Andraweera, P. H., & Marshall, H. S. (2023). A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529). Vaccines, 11(2), 1-19. Scopus36 WoS32 Europe PMC31 |
| 2023 | Yanni, M., Stark, M., Francis, L., Francis, J. R., McMillan, M., Baird, R., . . . Marshall, H. S. (2023). Neonatal Group B Streptococcal Infection in Australia: A Case-control Study.. The Pediatric Infectious Disease Journal, 42(5), 429-435. Scopus4 WoS4 Europe PMC3 |
| 2023 | Wang, B., Giles, L., Andraweera, P., McMillan, M., Almond, S., Beazley, R., . . . Marshall, H. (2023). 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post program implementation. Journal of Infection, 87(2), 95-102. Scopus39 WoS38 Europe PMC39 |
| 2022 | McMillan, M., Marshall, H. S., & Richmond, P. (2022). 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines, 21(1), 103-114. Scopus6 WoS5 Europe PMC6 |
| 2022 | Wang, B., Giles, L., Andraweera, P., McMillan, M., Almond, S., Beazley, R., . . . Marshall, H. (2022). Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. The Lancet Infectious Diseases, 22(7), 1011-1020. Scopus76 WoS73 Europe PMC72 |
| 2022 | McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., Bednarz, J., MacLennan, J. M., . . . Marshall, H. S. (2022). 'B Part of It' School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria meningitidis. Journal of Infectious Diseases, 225(4), 637-649. Scopus8 WoS8 Europe PMC6 |
| 2022 | McMillan, M., Bednarz, J., Leong, L. E. X., Lawrence, A., & Marshall, H. S. (2022). Impact of COVID-19 Containment Strategies and Meningococcal Conjugate ACWY Vaccination on Meningococcal Carriage in Adolescents. Pediatric Infectious Disease Journal, 41(11), e468-e474. Scopus8 WoS8 Europe PMC8 |
| 2021 | Mohammed, H., McMillan, M., Andraweera, P. H., Elliott, S. R., & Marshall, H. S. (2021). A rapid global review of strategies to improve influenza vaccination uptake in Australia.. Human vaccines & immunotherapeutics, 17(12), 1-13. Scopus13 WoS13 Europe PMC13 |
| 2021 | Marshall, H. S., Andraweera, P. H., Wang, B., McMillan, M., Koehler, A. P., Lally, N., . . . Flood, L. (2021). Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol. Human Vaccines and Immunotherapeutics, 17(5), 1450-1454. Scopus13 WoS12 Europe PMC10 |
| 2021 | McMillan, M., Wang, B., Koehler, A. P., Sullivan, T. R., & Marshall, H. S. (2021). Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents.. Clin Infect Dis, 73(1), e233-e237. Scopus32 WoS27 Europe PMC23 |
| 2021 | Mohammed, H., McMillan, M., & Marshall, H. S. (2021). Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics, 18(1), 1-9. WoS1 |
| 2021 | McMillan, M., Walters, L., Sullivan, T., Leong, L. E. X., Turra, M., Lawrence, A., . . . Marshall, H. S. (2021). Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(1), e99-e106. Scopus20 WoS16 Europe PMC10 |
| 2020 | McMillan, M., Chandrakumar, A., Wang, H. L. R., Clarke, M., Sullivan, T. R., Andrews, R. M., . . . Marshall, H. S. (2020). Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), E609-E619. Scopus52 WoS45 Europe PMC36 |
| 2020 | Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., MacLennan, J. M., . . . Richmond, P. (2020). Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. The New England Journal of Medicine, 382(4), 318-327. Scopus163 WoS143 Europe PMC117 |
| 2020 | Menzies, R., Heron, L., Lampard, J., McMillan, M., Joseph, T., Chan, J., . . . Marshall, H. (2020). A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants. Vaccine, 38(15), 3137-3142. Scopus16 WoS18 Europe PMC17 |
| 2019 | Wooldridge, A. L., McMillan, M., Kaur, M., Giles, L. C., Marshall, H. S., & Gatford, K. L. (2019). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review. Journal of Allergy and Clinical Immunology, 144(6), 1703-1713. Scopus19 WoS18 Europe PMC18 |
| 2019 | Marshall, H., McMillan, M., Wang, B., Booy, R., Afzali, H., Buttery, J., . . . Barton, B. (2019). AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.. BMJ Open, 9(12), e032583. Scopus4 WoS4 Europe PMC3 |
| 2019 | McMillan, M., Walters, L., Mark, T., Lawrence, A., Leong, L., Sullivan, T., . . . Marshall, H. (2019). B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Human Vaccines and Immunotherapeutics, 15(4), 987-994. Scopus31 WoS28 Europe PMC25 |
| 2019 | Mohammed, H., McMillan, M., Roberts, C. T., & Marshall, H. S. (2019). A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.. PloS one, 14(3), 0214538. Scopus39 WoS37 Europe PMC30 |
| 2019 | Marshall, H., McMillan, M., Koehler, A., Lawrence, A., MacLennan, J., Maiden, M., . . . Vadivelu, K. (2019). B part of it school leaver protocol: An observational repeat cross-sectional study to assess the impact of a meningococcal serogroup b (4cmenb) vaccine programme on carriage of neisseria meningitidis. BMJ Open, 9(5), 1-7. Scopus8 WoS7 Europe PMC3 |
| 2018 | Marshall, H. S., McMillan, M., Koehler, A., Lawrence, A., Maclennan, J. M., Maiden, M. C. J., . . . Vadivelu, K. (2018). B Part of It protocol: A cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open, 8(7), 9 pages. Scopus32 WoS25 Europe PMC24 |
| 2017 | McMillan, M., Clarke, M., Parrella, A., Fell, D., Amirthalingam, G., & Marshall, H. (2017). Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstetrics and Gynecology, 129(3), 560-573. Scopus90 WoS71 Europe PMC60 |
| 2017 | Amdany, H., McMillan, M., & Kiptoo, P. (2017). Antimalarial prescription in a public hospital outpatient setting in Kenya: A best practice implementation project. International Journal of Evidence-Based Healthcare, 15(1), 30-39. |
| 2016 | Marshall, H., McMillan, M., Andrews, R., Macartney, K., & Edwards, K. (2016). Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856. Scopus74 WoS69 Europe PMC57 |
| 2016 | Da Silva, F. T., Gonik, B., McMillan, M., Keech, C., Dellicour, S., Bhange, S., . . . Munoz, F. M. (2016). Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine, 34(49), 6057-6068. Scopus136 WoS130 Europe PMC129 |
| 2016 | DeSilva, M., Munoz, F. M., Mcmillan, M., Kawai, A. T., Marshall, H., Macartney, K. K., . . . Kharbanda, E. O. (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026. Scopus104 WoS91 Europe PMC78 |
| 2016 | Wooldridge, A. L., McMillan, M., Marshall, H. S., & Gatford, K. L. (2016). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 14(11), 11-20. Scopus4 Europe PMC1 |
| 2015 | McMillan, M., Porritt, K., Kralik, D., Costi, L., & Marshall, H. (2015). Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine, 33(18), 2108-2117. Scopus133 WoS123 Europe PMC107 |
| 2014 | Nyakiba, J., McMillan, M., & Kenyatta, G. (2014). Reporting and documentation of adverse drug reactions by health care professionals at a Kenyan public hospital: a best practice implementation project. JBI Database of Systematic Reviews and Implementation Reports, 12(7), 521-533. |
| 2014 | McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2014). Influenza vaccination during pregnancy: A systematic review of effectiveness and safety. JBI Database of Systematic Reviews and Implementation Reports, 12(6), 281-381. Scopus4 |
| 2014 | Amdany, H., & McMillan, M. (2014). Metronidazole intravenous formulation use in in-patients in Kapkatet District Hospital, Kenya: A best practice implementation project. JBI Database of Systematic Reviews and Implementation Reports, 12(3), 419-432. Scopus1 |
| 2014 | Davis, J., McMillan, M., Swaminathan, A., Kelly, J., Piera, K., Baird, R., . . . Anstey, N. (2014). A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia. Chest, 146(4), 1038-1045. Scopus58 WoS55 Europe PMC45 |
| 2012 | McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2012). Influenza vaccination during pregnancy: A systematic review of effectiveness and adverse effects. JBI Database of Systematic Reviews and Implementation Reports, 10(56 Suppl), S216-S226. Scopus1 Europe PMC8 |
| 2011 | Davis, J., Cheng, A., Mcmillan, M., Humphrey, A., Stephens, D., & Anstey, N. (2011). Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians. Medical Journal of Australia, 194(10), 519-524. Scopus75 WoS72 Europe PMC62 |
| 2010 | McMillan, M., & Davis, J. S. (2010). Acute hospital admission for sepsis: an important but under‐utilised opportunity for smoking cessation interventions. Australian and New Zealand Journal of Public Health, 34(4), 432-433. Scopus2 WoS2 Europe PMC1 |
| 2009 | Davis, J. S., Yeo, T. W., Thomas, J. H., McMillan, M., Darcy, C. J., McNeil, Y. R., . . . Anstey, N. M. (2009). Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: An observational study. Critical Care, 13(5), 9 pages. Scopus53 WoS49 Europe PMC51 |
| 2008 | Davis, J. S., Thomas, J., McMillan, M., Yeo, T., Celermajer, D., Stephens, D., & Anstey, N. M. (2008). Finger reactive hyperaemia to measure endothelial function in sepsis and health (the FRESH study).. Critical care (London, England), 12(Suppl 2), P64. Europe PMC1 |
| 2000 | McMillan, M. (2000). Examining PerlCOM. DR DOBBS JOURNAL, 25(1), 84-+. |
| 1994 | ENSLEY, R. D., IVES, M., ZHAO, L. P., MCMILLAN, M., SHELBY, J., & BARRY, W. H. (1994). EFFECTS OF ALLOIMMUNE INJURY ON CONTRACTION AND RELAXATION IN CULTURED MYOCYTES AND INTACT CARDIAC ALLOGRAFTS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 24(7), 1769-1778. WoS12 |
| 1991 | WOODLEY, S. L., MCMILLAN, M., SHELBY, J., LYNCH, D. H., ROBERTS, L. K., ENSLEY, R. D., & BARRY, W. H. (1991). MYOCYTE INJURY AND CONTRACTION ABNORMALITIES PRODUCED BY CYTOTOXIC LYMPHOCYTES-T. CIRCULATION, 83(4), 1410-1418. WoS49 |
| - | Leong, L. E. X., Coldbeck-Shackley, R. C., McMillan, M., Bratcher, H. B., Turra, M., Lawrence, A. J., . . . Marshall, H. S. (n.d.). Effect of 4cmenb Vaccination on the Genomic Epidemiology of Neisseria Meningitidis Oropharyngeal Carriage in an Asymptomatic Adolescent Population. |
| Year | Citation |
|---|---|
| 2014 | Jordan, Z., McArthur, A., & McMillan, M. (2014). Stakeholder Engagement: The Role of Tacit Knowledge and Value Statements in Translation Science. Online: Lippincott Williams & Wilkins. |
| Year | Citation |
|---|---|
| 1990 | ENSLEY, R. D., MCMILLAN, M., SHELBY, J., & BARRY, W. H. (1990). EFFECTS OF ALLOSENSITIZED CYTOTOXIC LYMPHOCYTES-T MYOCYTE [CA-2+]1 TRANSIENTS AND CONTRACTION. In CIRCULATION Vol. 82 (pp. 629). AMER HEART ASSOC. |
| 1990 | IKENOUCHI, H., KOHMOTO, O., MCMILLAN, M., & BARRY, W. H. (1990). EFFECTS OF METABOLIC INHIBITION ON RELAXATION, [CA-2+]I, [PI]I, AND PHI IN VENTRICULAR MYOCYTES. In CIRCULATION Vol. 82 (pp. 569). AMER HEART ASSOC. |
| Year | Citation |
|---|---|
| 2022 | Yanni, M., Stark, M., Francis, L., Francis, J., McMillan, M., Faeron, D., . . . Marshall, H. (2022). Incidence and risk factors for neonatal group B streptococcal infection in Australia. Poster session presented at the meeting of Communicable Diseases & Immunisation Conference. Sydney. |
| 2022 | McMillan, M., Bednarz, J., Leong, L., Lawrence, A., & Marshall, H. (2022). Impact of COVID-19 containment strategies and MenACWY vaccination on carriage of meningococci. Poster session presented at the meeting of Communicable Diseases & Immunisation Conference. |
| 2021 | McMillan, M., Koehler, A., Lawrence, A., Sullivan, T., Bednarz, J., MacLennan, J., . . . Marshall, H. (2021). B Part of It’ School Leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with 4CMenB vaccine on meningococcal carriage. Poster session presented at the meeting of 38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). |
| 2019 | McMillan, M., Walters, L., Koehler, A., Leong, L., Turra, M., Lawrence, A., . . . Marshall, H. (2019). 'B Part of It study’ Impact of 4CMenB vaccine on meningococcal carriage density in adolescents. Poster session presented at the meeting of 37th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Ljubljana, Slovenia. |
| 2018 | McMillan, M., Walters, L., Turra, M., Lawrence, A., Sullivan, T., Leong, L., . . . Marshall, H. (2018). ‘B Part of It study’: Carriage of Neisseria meningitidis in first year university students in South Australia; a longitudinal study. Poster session presented at the meeting of 16th National Immunisation Conference. Adelaide. |
| 2017 | McMillan, M., Heron, L., Braunack-Mayer, A., Menzies, R., Lampard, J., Joseph, T., . . . Marshall, H. (2017). Randomised controlled trial: SMS and calendar reminders to promote infant immunisation timeliness.. Poster session presented at the meeting of N/A. Hobart. |
| 2017 | McMillan, M., Heron, L., Braunack-Mayer, A., Menzies, R., Lampard, J., Joseph, T., . . . Marshall, H. (2017). Randomised controlled trial: SMS and calendar reminders to promote infant immunisation timeliness.. Poster session presented at the meeting of N/A. Hobart. |
| 2015 | McMillan, M., Porritt, K., Costi, L., & Marshall, H. (2015). Influenza vaccination during pregnancy: A systematic review of fetal safety. Poster session presented at the meeting of EPSID Abstracts. Leipzig, Germany. |
| Year | Citation |
|---|---|
| 2023 | McMillan, M., Mohammed, H., Saunders, L., Clarke, M., & Marshall, H. (2023). School immunisation program review South Australia. |
| 2022 | McMillan, M., Mohammed, H., Wang, B., Saunders, L., Clarke, M., McDonough, J., & Marshall, H. (2022). Review of the COVID-19 vaccine program in South Australia. |
| 2021 | Elliott, S., Andraweera, P., McMillan, M., Evans, S., Wang, B., Mohammed, H., . . . Marshall, H. (2021). Review of 2020 Influenza vaccine distribution in South Australia. |
| 2021 | Elliott, S., Andraweera, P., McMillan, M., Evans, S., Wang, B., Mohammed, H., . . . Marshall, H. (2021). Review of 2020 Influenza vaccine distribution in South Australia. |
| 2014 | Nori, A., Piovesan, R., O’Connor, J., Graham, A., Shah, S., Rigney, D., . . . Brown, N. (2014). 'Y Health - Staying Deadly': an Aboriginal youth focused translational action research project. Australian National University. |
| 2013 | White, S., Moola, S., McMillan, M., Riitano, D., & Aromataris, E. C. (2013). Unplanned hospital readmission rates and there use in clinical practice and health service management: a rapid review. |
| Year | Citation |
|---|---|
| 2021 | McMillan, M. (2021). Impact of meningococcal vaccines on carriage and disease. (PhD Thesis). |
| 2014 | McMillan, M. (2014). Influenza vaccination during pregnancy: a systematic review of effectiveness and safety.. (Master's Thesis). |
| Year | Citation |
|---|---|
| 2015 | Mcmillan, M., Parrella, A., Clarke, M., & Marshall, H. (2015). A systematic review of the safety of diphtheria, tetanus, pertussis, and inactivated polio antigen containing vaccines administered during pregnancy. PROTOCOL. |
2024 CIJ - Centre for Research Excellence in Neisseria disease control (CIA Marshall, $3 million).
2023 CIA - Women’s & Children’s Hospital Foundation Postdoctoral Fellowship – ‘long-COVID and repeat infections on the health and wellbeing of children and adolescents’ ($386,384).
2022 CIA - RRI Engaging Opportunities program – ‘Generating evidence to inform the introduction of maternal group B streptococcal vaccination to reduce stillbirth and infant death’ ($10,000).
2020 Co-investigator on a study investigating the long-term effectiveness of meningococcal B vaccine (4CMenB) against gonorrhoea (CIAs Marshall and Ward, $1 million).